JP2020055851A5 - - Google Patents

Download PDF

Info

Publication number
JP2020055851A5
JP2020055851A5 JP2019220904A JP2019220904A JP2020055851A5 JP 2020055851 A5 JP2020055851 A5 JP 2020055851A5 JP 2019220904 A JP2019220904 A JP 2019220904A JP 2019220904 A JP2019220904 A JP 2019220904A JP 2020055851 A5 JP2020055851 A5 JP 2020055851A5
Authority
JP
Japan
Prior art keywords
combinations
group
ophthalmic composition
surfactant selected
treating presbyopia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019220904A
Other languages
English (en)
Japanese (ja)
Other versions
JP7358221B2 (ja
JP2020055851A (ja
Filing date
Publication date
Priority claimed from JP2018199733A external-priority patent/JP2019031538A/ja
Application filed filed Critical
Publication of JP2020055851A publication Critical patent/JP2020055851A/ja
Publication of JP2020055851A5 publication Critical patent/JP2020055851A5/ja
Priority to JP2021133867A priority Critical patent/JP7329019B2/ja
Application granted granted Critical
Publication of JP7358221B2 publication Critical patent/JP7358221B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019220904A 2013-08-28 2019-12-06 老視を治療するための組成物及び方法 Active JP7358221B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021133867A JP7329019B2 (ja) 2013-08-28 2021-08-19 老視を治療するための組成物及び方法

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201361871215P 2013-08-28 2013-08-28
US61/871,215 2013-08-28
US201361882998P 2013-09-26 2013-09-26
US61/882,998 2013-09-26
US201361904510P 2013-11-15 2013-11-15
US61/904,510 2013-11-15
US201361917620P 2013-12-18 2013-12-18
US61/917,620 2013-12-18
US201461938438P 2014-02-11 2014-02-11
US61/938,438 2014-02-11
JP2018199733A JP2019031538A (ja) 2013-08-28 2018-10-24 老視を治療するための組成物及び方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018199733A Division JP2019031538A (ja) 2013-08-28 2018-10-24 老視を治療するための組成物及び方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021133867A Division JP7329019B2 (ja) 2013-08-28 2021-08-19 老視を治療するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2020055851A JP2020055851A (ja) 2020-04-09
JP2020055851A5 true JP2020055851A5 (https=) 2020-05-21
JP7358221B2 JP7358221B2 (ja) 2023-10-10

Family

ID=52584080

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2016538985A Active JP6426743B2 (ja) 2013-08-28 2014-08-22 老視を治療するための組成物及び方法
JP2018199733A Ceased JP2019031538A (ja) 2013-08-28 2018-10-24 老視を治療するための組成物及び方法
JP2019220904A Active JP7358221B2 (ja) 2013-08-28 2019-12-06 老視を治療するための組成物及び方法
JP2021133867A Active JP7329019B2 (ja) 2013-08-28 2021-08-19 老視を治療するための組成物及び方法
JP2023081444A Pending JP2023103400A (ja) 2013-08-28 2023-05-17 老視を治療するための組成物及び方法
JP2025093153A Pending JP2025131705A (ja) 2013-08-28 2025-06-04 老視を治療するための組成物及び方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016538985A Active JP6426743B2 (ja) 2013-08-28 2014-08-22 老視を治療するための組成物及び方法
JP2018199733A Ceased JP2019031538A (ja) 2013-08-28 2018-10-24 老視を治療するための組成物及び方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021133867A Active JP7329019B2 (ja) 2013-08-28 2021-08-19 老視を治療するための組成物及び方法
JP2023081444A Pending JP2023103400A (ja) 2013-08-28 2023-05-17 老視を治療するための組成物及び方法
JP2025093153A Pending JP2025131705A (ja) 2013-08-28 2025-06-04 老視を治療するための組成物及び方法

Country Status (22)

Country Link
US (1) US9089562B2 (https=)
EP (3) EP3542798B1 (https=)
JP (6) JP6426743B2 (https=)
KR (4) KR20160045147A (https=)
CN (1) CN105792815B (https=)
AU (2) AU2014311558B2 (https=)
CA (1) CA2922802C (https=)
DK (1) DK3542798T3 (https=)
ES (1) ES3028364T3 (https=)
FI (1) FI3542798T3 (https=)
HK (1) HK1225654A1 (https=)
HR (1) HRP20250507T1 (https=)
HU (1) HUE071646T2 (https=)
LT (1) LT3542798T (https=)
MX (2) MX393360B (https=)
PL (1) PL3542798T3 (https=)
PT (1) PT3542798T (https=)
RS (1) RS66821B1 (https=)
SG (1) SG11201601412XA (https=)
SI (1) SI3542798T1 (https=)
SM (1) SMT202500311T1 (https=)
WO (1) WO2015031186A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113525C2 (xx) 2011-09-20 2017-02-10 Спосіб лікування пресбіопії
US9089562B2 (en) * 2013-08-28 2015-07-28 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
CN106455567A (zh) * 2013-12-18 2017-02-22 Gnt有限责任公司 用于治疗青光眼的组合物和方法
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
WO2016205071A1 (en) * 2015-06-18 2016-12-22 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
KR20180014825A (ko) * 2015-06-18 2018-02-09 프레스바이오피아 세라피스, 엘엘씨 눈의 굴절 이상 치료 및 원거리 시력 개선용 조성물 및 방법
CN106526888B (zh) * 2015-09-15 2019-08-06 星欧光学股份有限公司 隐形眼镜产品
US10845622B2 (en) 2015-09-15 2020-11-24 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
US12298602B2 (en) 2015-09-15 2025-05-13 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
PT3500255T (pt) * 2016-08-19 2023-01-10 Orasis Pharmaceuticals Ltd Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
IT201700069664A1 (it) * 2017-06-22 2018-12-22 For Health Pharma S R L Nuova formulazione oftalmica a base di tropicamide
JP7170436B2 (ja) * 2017-06-28 2022-11-14 千寿製薬株式会社 水溶性高分子を含む点眼剤
CA3070556A1 (en) * 2017-07-20 2019-01-24 Alan Laboratories, Inc. Compositions and methods for treatment of myopia
JP6603785B2 (ja) * 2017-12-08 2019-11-06 千寿製薬株式会社 水溶性高分子を含む水性液剤
PL3681500T3 (pl) 2018-04-24 2022-08-01 Allergan, Inc. Zastosowanie chlorowodorku pilokarpiny w leczeniu starczowzroczności
TW202021584A (zh) * 2018-08-21 2020-06-16 美商歐樂根公司 α2 腎上腺素受體促效劑用於改善視力之用途
JP2020033290A (ja) * 2018-08-29 2020-03-05 興和株式会社 水性組成物
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
US10836760B2 (en) 2018-10-10 2020-11-17 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
WO2020252057A1 (en) * 2019-06-10 2020-12-17 Visus Therapeutics, Inc. Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality
CN114502155A (zh) * 2019-06-10 2022-05-13 视觉治疗股份有限公司 增强抗老视作用的卡巴胆碱-溴莫尼定制剂
CA3147107A1 (en) * 2019-07-26 2021-02-04 Allergan, Inc. Compositions and methods for treatment of presbyopia
WO2021236671A1 (en) * 2020-05-18 2021-11-25 Vyluma Inc. Low-dose carbachol compositions and methods for treatment of night vision disturbance
US20230190738A1 (en) * 2021-12-16 2023-06-22 Lenz Therapeutics, Inc. Compositions and methods for the treatment of eye conditions
PL4312986T3 (pl) * 2021-04-01 2025-02-17 Active Biotech Ab Preparat lakwinimodu do stosowania do oczu
WO2022232205A1 (en) * 2021-04-28 2022-11-03 Lenz Therapeutics, Inc. A method of reducing brow ache
KR102415950B1 (ko) 2021-07-13 2022-07-05 백두하 백국화 추출물, 모과 추출물 및 용안육 추출물의 혼합물을 유효성분으로 포함하는 눈 건강 기능 식품 및 이의 제조방법
TW202333662A (zh) * 2021-11-10 2023-09-01 美商偉視醫療股份有限公司 增強抗老花眼效果之卡巴可(carbachol)調配物
WO2023091439A1 (en) * 2021-11-17 2023-05-25 Lenz Therapeutics, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US11648247B1 (en) 2021-12-16 2023-05-16 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia
CN114588156B (zh) * 2022-04-22 2024-06-11 温州医科大学附属眼视光医院 一种眼用制剂及其在治疗老花眼中的应用
KR102678138B1 (ko) * 2022-09-29 2024-06-25 주식회사태준제약 브리모니딘을 포함하는 안과용 조성물
KR20240099055A (ko) * 2022-12-21 2024-06-28 주식회사 대웅테라퓨틱스 이나보글리플로진을 포함하는 점안제 형태의 약학 조성물
WO2024220441A1 (en) * 2023-04-17 2024-10-24 Lenz Therapeutics Operations, Inc. Methods for the treatment of presbyopia
CN119789854A (zh) * 2023-08-04 2025-04-08 Ads医疗有限责任公司 用于递送眼科活性物的组合物和方法
CN119700989A (zh) * 2023-09-28 2025-03-28 苏州普乐康医药科技有限公司 一种α-肾上腺素受体激动剂眼用组合物及其用途
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia
WO2025259674A1 (en) * 2024-06-11 2025-12-18 Ads Therapeutics Llc Compositions and methods for delivery of pharmaceutical actives

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
CA2031469A1 (en) * 1989-12-28 1991-06-29 Larry A. Wheeler Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension
US5073560A (en) * 1990-07-20 1991-12-17 Fisons Corporation Spiro-isoxazolidine derivatives as cholinergic agents
US6291466B1 (en) * 1998-07-30 2001-09-18 Allergan Sales, Inc. Cholinergic agents in the treatment of presbyopia
ITMI20010708A1 (it) * 2001-04-03 2002-10-03 Alessandro Randazzo Trattamento farmacologico degli aloni notturni e delle immagini fantasma con parasimpaticomimetici diluiti aceclidina/pilocarpina dopo inter
AR034371A1 (es) 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
JP2003201241A (ja) 2001-10-22 2003-07-18 Rohto Pharmaceut Co Ltd 眼科用組成物
JP2004168709A (ja) * 2002-11-20 2004-06-17 Nidek Co Ltd 抗アレルギー点眼点鼻用組成物
US20060177430A1 (en) 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US8663639B2 (en) * 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
JP2008536866A (ja) 2005-04-15 2008-09-11 ボード、オブ、トラスティーズ、オブ、ミシガン、ステイト、ユニバーシティ アミン作動性医薬組成物および方法
ES2329161T3 (es) 2006-12-18 2009-11-23 Jorge Luis Benozzi Composiciones oftalmicas de estimulantes parasimpaticos y antiinflamatorios para su uso en el tratamiento de la presbicia.
EP2097044A4 (en) * 2006-12-26 2012-10-10 Quadra Logic Tech Inc DRUG RELIEF IMPLANTS FOR INHIBITING OPTICAL DEFECTS
GB0724558D0 (en) 2007-12-15 2008-01-30 Sharma Anant Optical correction
US20110212142A1 (en) * 2008-11-17 2011-09-01 Laila Pharmaceuticals Pvt.Ltd. Curcuminoids and its metabolites for the application in ocular diseases
US8501800B2 (en) 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
WO2010125416A1 (en) * 2009-04-27 2010-11-04 Raouf Rekik Drug delivery to the anterior and posterior segments of the eye
WO2010135731A1 (en) 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
AU2009347921B8 (en) 2009-06-10 2014-07-24 Mitotech Sa Pharmaceutical composition for use in medical and veterinary ophthalmology
WO2011011519A1 (en) * 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
JP2013523825A (ja) * 2010-04-07 2013-06-17 アラーガン インコーポレイテッド 眼科製剤のための保存剤組成物の組み合わせ
WO2011127151A2 (en) * 2010-04-07 2011-10-13 Allergan, Inc. Combinations of preservatives for ophthalmic compositions
JP2014506936A (ja) 2011-03-03 2014-03-20 アラーガン インコーポレイテッド シリコーンベースの眼科製剤
UA113525C2 (xx) 2011-09-20 2017-02-10 Спосіб лікування пресбіопії
US9089562B2 (en) * 2013-08-28 2015-07-28 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia

Similar Documents

Publication Publication Date Title
JP2020055851A5 (https=)
Biswas et al. Highly dispersive optical solitons with cubic-quintic-septic law by F-expansion
MX2017013533A (es) Composiciones de limpieza personal concentradas.
MX390521B (es) Composiciones con polimeros anionicos y cationicos
EP4324919A3 (en) Polypeptide variants
MX367204B (es) Métodos y composiciones de limpieza personal concentradas.
BR112017005495A2 (pt) composição de detergente para lavagem de roupas e método doméstico de tratamento de um tecido
MX2022006145A (es) Anticuerpos trem2 y usos de estos.
AR068584A1 (es) Composiciones para el tratamiento de las telas
MX2024009207A (es) Mejora en o con relacion a compuestos organicos
FI3692023T3 (fi) Bentsotiatsoliyhdisteitä ja menetelmiä niiden käyttämiseksi neurodegeneratiivisten häiriöiden hoitoon
MY196448A (en) Anti-Htra1 Antibodies and Methods of use Thereof
MX2017013534A (es) Composiciones concentradas para la limipieza personal y usos.
UA46442S (uk) 1. смартфон
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
BR112021022167A2 (pt) Composição de lavanderia auxiliar, método para administrar enzimas a tecidos, método para aprimorar o benefício amaciante de um condicionador de tecido e uso de uma composição de lavanderia auxiliar
EP4524225A3 (en) Protease variants and detergent compositions comprising same
CR20220204A (es) Extracto de algas concentrado
PH12022550328A1 (en) Compositions comprising tigolaner for controlling parasites
MX2021003075A (es) Composiciones para el cuidado del hogar.
MX2021002834A (es) Una composicion para el cuidado de tejidos que comprende polialquilenimina modificada hidrofobicamente como polimero fijador de tinte.
MX2019004163A (es) Composiciones de agente tensoactivo tipo geminis y tipo oligomerico.
EA202192786A1 (ru) Твердые формы (e)-3-[2-(2-тиенил)винил]-1h-пиразола
JP2019094312A5 (https=)
HK1246206A1 (zh) 用於治疗青光眼的组合物和方法